Department of Brain & Cognitive SCIENCES
Faculty

Research Highlights

2020 Dopamine dysregulation in psychotic relapse after antipsychotic discontinuation: an [18F]DOPA and [11C]raclopride PET study in first-episode psychosis

페이지 정보

작성자 최고관리자 작성일 24-07-03 15:43

본문

Professor
Euitae Kim
Authors
Seoyoung Kim, Sang Ho Shin, Barbara Santangelo, Mattia Veronese, Seung Kwan Kang, Jae Sung Lee, Gi Jeong Cheon, Woojoo Lee, Jun Soo Kwon, Oliver D. Howes, Euitae Kim
Journal
Molecular Psychiatry
Journal Info
26(7)
Year
2020
Antipsychotic drugs are commonly prescribed to help relieve symptoms in patients experiencing their first episode of psychosis. However, there's a high risk of relapse when these medications are stopped, and the reasons behind this are not well understood. This study looked into what happens in the brain when antipsychotic drugs are discontinued. Researchers compared the brain’s capacity to produce dopamine in the striatum and its receptor availability in first-episode psychosis patients before and six weeks after they stopped taking antipsychotic drugs. They also included healthy volunteers for comparison. The study found significant changes in the dopamine synthesis capacity in patients who relapsed compared to those who remained stable and healthy volunteers during the six weeks without medication. However, there was no significant difference in the availability of dopamine receptors among the relapsed patients, non-relapsed patients, and healthy controls. These findings suggest that abnormal dopamine synthesis in striatum may trigger psychotic relapse after stopping antipsychotic drugs in patients with first-episode psychosis. This insight could help improve strategies for preventing relapse in these patients.
go top